Literature DB >> 18506268

[Diabetic retinopathy risk factors].

Jorge Esteves1, Andréia F Laranjeira, Murilo F Roggia, Melissa Dalpizol, Caio Scocco, Caroline K Kramer, Mirela J Azevedo, Luís H Canani.   

Abstract

Diabetic retinopathy (DR) occurs in about 95% of patients with type 1 diabetes mellitus (DM) and in 60% of type 2 DM patients and it is the main cause of legal blindness in adult people. The aim of this manuscript was to review the main risk factors for DR. The major environmental risk factors are hyperglycemia, high blood pressure levels, and long-term duration of DM. However, not all patients will not develop DR, suggesting the presence of a genetic predisposition to DR, especially for severe forms of DR. Special strategies has been used to evaluate the genetic role in DR. Family studies shown that there is a familial aggregation of DR. Candidates genes have been studied (RAGE; VEGF; PPAR-delta; ICAM-1; ECA; ENPP 1; eNOS) and positive or negative associations with DR were demonstrated. Some chromosomes were also associated to DR in selected populations. Finally, genetic expression studies reinforce the association of candidate genes, or participation of others genes, with the presence of DR. DR is a common complication of DM and, along with non-genetic or environmental risk factors, the identification of genes related to DR could result in more specific and efficient DR treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506268     DOI: 10.1590/s0004-27302008000300003

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  10 in total

1.  An analysis of the association between a polymorphism of KCNJ11 and diabetic retinopathy in a Chinese Han population.

Authors:  Nai-Jia Liu; Hui-Hui Wu; Yan-Liang Li; Zhen Yang; Xiao-Ming Tao; Yan-Ping Du; Xuan-Chun Wang; Bin Lu; Zhao-Yun Zhang; Ren-Ming Hu; Jie Wen
Journal:  Eur J Med Res       Date:  2015-01-09       Impact factor: 2.175

2.  High prevalence of lower extremity peripheral artery disease in type 2 diabetes patients with proliferative diabetic retinopathy.

Authors:  Yi-Wen Chen; Ying-Ying Wang; Dong Zhao; Cai-Guo Yu; Zhong Xin; Xi Cao; Jing Shi; Guang-Ran Yang; Ming-Xia Yuan; Jin-Kui Yang
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Risk factors for diabetic retinopathy: a case-control study.

Authors:  Vinícius Carriero Lima; Gabriela Coutinho Cavalieri; Maurício Carriero Lima; Nazaré Otília Nazario; Gina Carriero Lima
Journal:  Int J Retina Vitreous       Date:  2016-09-12

4.  Methylenetetrahydrofolate reductase C677T polymorphism and diabetic retinopathy risk: a meta-analysis of the Chinese population.

Authors:  Wei-Hai Xu; Ying Zhuang; Xiao Han; Zhi-Lan Yuan
Journal:  J Int Med Res       Date:  2019-01-10       Impact factor: 1.671

5.  Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation.

Authors:  Jorge Esteves; Carolina Maurente da Rosa; Caroline Kaercher Kramer; Luiz Eduardo Osowski; Stéfano Milano; Luís Henrique Canani
Journal:  Diabetol Metab Syndr       Date:  2009-10-05       Impact factor: 3.320

6.  Plasma plasminogen activator inhibitor-1 is associated with end-stage proliferative diabetic retinopathy in the Northern Chinese Han population.

Authors:  Ze-long Zhong; Song Chen
Journal:  Exp Diabetes Res       Date:  2012-10-14

7.  Application of random forests methods to diabetic retinopathy classification analyses.

Authors:  Ramon Casanova; Santiago Saldana; Emily Y Chew; Ronald P Danis; Craig M Greven; Walter T Ambrosius
Journal:  PLoS One       Date:  2014-06-18       Impact factor: 3.240

Review 8.  Mesenchymal stem cell therapy in type 2 diabetes mellitus.

Authors:  Li Zang; Haojie Hao; Jiejie Liu; Yijun Li; Weidong Han; Yiming Mu
Journal:  Diabetol Metab Syndr       Date:  2017-05-15       Impact factor: 3.320

9.  Serum Iron and Risk of Diabetic Retinopathy.

Authors:  Ying-Jen Chen; Jiann-Torng Chen; Ming-Cheng Tai; Chang-Min Liang; Yuan-Yuei Chen; Wei-Liang Chen
Journal:  Nutrients       Date:  2020-07-31       Impact factor: 5.717

10.  Bone Marrow-Derived Mesenchymal Stem Cells Restored High-Fat-Fed Induced Hyperinsulinemia in Rats at Early Stage of Type 2 Diabetes Mellitus.

Authors:  Gongchi Li; Han Peng; Shen Qian; Xinhua Zou; Ye Du; Zhi Wang; Lijun Zou; Zibo Feng; Jing Zhang; Youpeng Zhu; Huamin Liang; Binghui Li
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.